Increased expression of PTCH1 and GLI1 in Bangladeshi TNBC Patients after Treatment with Doxorubicin and Cyclophosphamide Suggests a Favorable Response to Chemotherapy

Document Type : Research Articles

Authors

• Ramendu Parial ^{1, 2}
• Shafiqul Islam ^{1, 2}
• Ridwan Ahmed ^{1, 2}
• Nusrat Jerin ^{1, 2}
• S.M. Sabbir Alam ^{1, 2}
• Md. Mizanur Rahman ^{1, 2, 3}
• Ali Asgar Chowdhury ⁴
• Shakera Ahmed ⁵
• Mohammed Moinul Islam ^{1, 2}
• Abu Shadat Mohammod Noman ^{1, 2}
• Muhammad Mosaraf Hossain ^{1, 2}

¹ Department of Biochemistry & Molecular Biology, University of Chittagong, Chattogram-4331, Bangladesh.

² EuGEF Research Foundation, Chattogram, Bangladesh.

³ Rangamati Medical College, Rangamati, Bangladesh.

⁴ Department of Radiotherapy, Chittagong Medical College, Chattogram, Bangladesh.

⁵ Department of Surgery, Chittagong Medical College, Chattogram, Bangladesh.

Abstract

Keywords

• Doxorubicin
• Cyclophosphamide
• Hh signaling
• TNBC

Main Subjects

• Cancer biology